title: ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.
abstract: Nocturnal hypoglycemia is a barrier to therapy intensification efforts in diabetes. The Paradigm® Veo™ system may mitigate nocturnal hypoglycemia by automatically suspending insulin when a prespecified sensor glucose threshold is reached. ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) In-Home (NCT01497938) was a multicenter, randomized, parallel, adaptive study of subjects with type 1 diabetes. The control arm used sensor-augmented pump therapy. The treatment arm used sensor-augmented pump therapy with threshold suspend, which automatically suspends the insulin pump in response to a sensor glucose value at or below a prespecified threshold. To be randomized, subjects had to have demonstrated ≥2 episodes of nocturnal hypoglycemia, defined as &gt;20 consecutive minutes of sensor glucose values ≤65 mg/dl starting between 10:00 PM and 8:00 AM in the 2-week run-in phase. The 3-month study phase evaluated safety by comparing changes in glycated hemoglobin (A1C) values and evaluated efficacy by comparing the mean area under the glucose concentration time curves for nocturnal hypoglycemia events in the two groups. Other outcomes included the rate of nocturnal hypoglycemia events and the distribution of sensor glucose values. Data from the ASPIRE In-Home study should provide evidence on the safety of the threshold suspend feature with respect to A1C and its efficacy with respect to severity and duration of nocturnal hypoglycemia when used at home over a 3-month period.
authors.affiliation: Mills-Peninsula Health Services, San Mateo, CA 94401, USA. dklonoff@diabetestechnology.org
authors.forename: David C
authors.initials: DC
authors.lastname: Klonoff
authors.forename: Richard M
authors.initials: RM
authors.lastname: Bergenstal
authors.forename: Satish K
authors.initials: SK
authors.lastname: Garg
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Bode
authors.forename: Melissa
authors.initials: M
authors.lastname: Meredith
authors.forename: Robert H
authors.initials: RH
authors.lastname: Slover
authors.forename: Andrew
authors.initials: A
authors.lastname: Ahmann
authors.forename: John B
authors.initials: JB
authors.lastname: Welsh
authors.forename: Scott W
authors.initials: SW
authors.lastname: Lee
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002940:Circadian Rhythm / Q000502:physiology; D002986:Clinical Trials as Topic / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006699:Home Care Services; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control*; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects*; D007332:Insulin Infusion Systems / Q000009:adverse effects; D008875:Middle Aged; D012107:Research Design; D012890:Sleep / Q000502:physiology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007328:Insulin
references.citation: J Diabetes Sci Technol. 2011 Nov 01;5(6):1466-71
references.pmid: 22226267
references.citation: Diabetes Technol Ther. 2012 Mar;14(3):205-9
references.pmid: 22316089
references.citation: Diabetes. 2005 Dec;54(12):3592-601
references.pmid: 16306382
references.citation: Diabetes Technol Ther. 2011 Jul;13(7):695-8
references.pmid: 21668344
references.citation: Diabetes. 1993 Dec;42(12):1791-8
references.pmid: 8243825
references.citation: Endocr Pract. 2010 Mar-Apr;16(2):244-8
references.pmid: 19833577
references.citation: Diabetes Technol Ther. 2011 Nov;13(11):1129-34
references.pmid: 21827318
references.citation: Diabetologia. 2002 Jul;45(7):937-48
references.pmid: 12136392
references.citation: Diabetes Care. 2012 Jul;35(7):1462-5
references.pmid: 22584133
references.citation: Diabetes Care. 2010 May;33(5):1013-7
references.pmid: 20200307
references.citation: Diabetes Care. 2011 Sep;34(9):2023-5
references.pmid: 21868778
references.citation: Diabetes Technol Ther. 2009 Feb;11(2):93-7
references.pmid: 19848575
references.citation: J Diabetes Sci Technol. 2011 Sep 01;5(5):1137-41
references.pmid: 22027306